These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 140270)

  • 1. [The influence of the beta-blocking agent pindolol on blood pressure and heart weight of rats with Goldblatt-type hypertension (author's transl)].
    Girndt J; Kramer A; Scheler F
    Klin Wochenschr; 1977 Apr; 55(7):349-50. PubMed ID: 140270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High dose betablocker treatment in experimental renal hypertension (author's transl)].
    Girndt J
    Klin Wochenschr; 1979 Aug; 57(15):793-5. PubMed ID: 40062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the beta-receptor-blocker prindolol on renal hypertension (author's transl)].
    Undeutsch K; Sieberth HG; Meurer KA
    Klin Wochenschr; 1976 Nov; 54(22):1077-84. PubMed ID: 1003866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency].
    De Ferrari G; Gaiter A; Ginevri F; Tizianello A
    Clin Ter; 1979 Sep; 90(5):461-8. PubMed ID: 399210
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
    Morgan TO; Roberts R; Carney SL; Louis WJ; Doyle AE
    Br J Clin Pharmacol; 1975 Apr; 2(2):159-64. PubMed ID: 791319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of beta-blocking agents on blood pressure and plasma renin activity in experimental renovascular hypertension (author's transl)].
    Takata M; Shimao M; Uno D; Arai S; Takabatake T; Nomura G; Hattori N
    Nihon Jinzo Gakkai Shi; 1977 Nov; 19(11):921-8. PubMed ID: 24774
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)].
    Werning C
    Med Klin; 1973 Nov; 68(47):1559-63. PubMed ID: 4781097
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood pressure and renin activity in essential hypertension under pindolol].
    Nussberger J; Vetter W; Furrer J; Beckerhoff R; Würsten D; Schmied U; Siegenthaler W
    Schweiz Med Wochenschr; 1976 Jun; 106(24):831-4. PubMed ID: 996500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term studies of the mechanisms of action of beta-blocking drugs in lowering blood pressure.
    Stumpe KO; Kolloch R; Vetter H; Gramann W; Krück F; Ressel C; Higuchi M
    Am J Med; 1976 May; 60(6):853-65. PubMed ID: 14499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients.
    Lancaster R; Goodwin TJ; Peart WS
    Br J Clin Pharmacol; 1976 Jun; 3(3):453-60. PubMed ID: 973972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pindolol--a new beta-adrenergic blocking agent with intrinsic sympathomimetic activity in the management of mild and moderate hypertension.
    Schirger A; Sheps SG; Spiekerman RE; Harman TR; Kleven MK
    Mayo Clin Proc; 1983 May; 58(5):315-8. PubMed ID: 6843182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic sympathomimetic activity counteracts beta-blocker inhibition of renin activation.
    Ruddy MC; Bialy GB; Kostis JB
    Angiology; 1989 Jan; 40(1):45-50. PubMed ID: 2562912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor-blocking drugs.
    Morgan T; Carney S; Roberts R
    Clin Sci Mol Med Suppl; 1975 Jun; 2():81s-83s. PubMed ID: 802647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of prindolol on the blood-pressure profile of hypertensives (with special consideration of response to exercise and plasma-renin activity) (author's transl)].
    Dufey K; Krönig B; Fries G; Gunkel R; Walter U; Wolff HP
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1726-30. PubMed ID: 1157670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
    Wessels F; Heinze A; Werth HW
    Med Klin; 1977 Oct; 72(41):1689-95. PubMed ID: 335203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and renin during treatment with pindolol.
    Fyhrquist F; Kurppa K; Huuskonen M; Koistinen A
    Acta Med Scand; 1977; 202(1-2):55-60. PubMed ID: 899884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.